Governor Phil Murphy (D) signed into law A-1259 / S-249  which requires pharmacy benefits managers providing services within the Medicaid program to disclose certain information to the Department of Human Services. Program to require the pharmacy benefits manager to disclose to the department: (1) all sources and amounts of income, payments, and financial benefits received by the pharmacy benefits manager in relation to the provision and administration of pharmacy benefits management services on behalf of the managed care organization, including, but not limited to, any pricing discounts, rebates of any kind, inflationary payments, credits, clawbacks, fees, grants, chargebacks, reimbursements, or other benefits; (2) all ingredient costs and dispensing fees or similar payments made by the pharmacy benefits manager to any pharmacy in connection with the contract or other arrangement; and (3) the pharmacy benefits manager’s payment model for administrative fees.  Information reported by pharmacy benefits managers under the bill will be confidential and will not be subject to disclosure under the “Open Public Records Act.” 

 This law goes into effect immediately. 

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

The New Jersey Board of Pharmacy is proposing to adopt regulations under NJAC 13:39-1 to require pharmacy permit holders and registered pharmacists-in-charge to implement a continuous quality improvement program to prevent prescription errors.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

The New Jersey Board of Pharmacy proposed to adopt regulations under NJAC 13:39-1 to require pharmacy permit holders and registered pharmacists-in-charge to implement a continuous quality improvement program to prevent prescription errors.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

Governor Phil Murphy (D) recently signed into law two opioid proposals. The first is AB 5595 which requires the Director of the Division of Consumer Affairs to include opioid antidotes on the list of prescription drugs provided to pharmacies and then requires pharmacies to include opioid antidotes on its prescription drug retail price list available to customers. Governor Murphy also signed into law AB 5703 which requires coverage for an opioid antidote without imposing prior authorization requirements.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

Governor Phil Murphy (D) signed into law A5820/S3866 ending the COVID 19 Public Health Emergency that has been in place since March 9, 2020. Many of the executive orders issued under the Public Health Emergency will expire by July 4, 2021.  Only Executive Orders that govern vaccinations and testing will remain in effect until January 11, 2022.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

This week the Assembly passed A4012/S2436 legislation which would authorize pharmacists to administer COVID19 testing.  The Senate passed an identical version earlier this year.  The bill has been sent to Governor Phil Murphy (D) for his signature and passage into law.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

This week, New Jersey joined Connecticut, Delaware, Massachusetts, New York, Pennsylvania, and Rhode Island in a regional pact to coordinate the regional reopening of the economy as the COVID-19 pandemic reaches its apex in the region.  The Pact shall include state officials, economic experts and public health officials.  No timeline or details are available, but the vision is a gradual return to work in the region.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.